ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,005Medicare Part D Prescriptions Filled, Including Refills

Rank: 146 out of 761

$614K Total Retail Price of All Prescriptions

Rank: 69 out of 761

640 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 640 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

10% of this provider’s 640 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 8,173 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 563 522 1 2
LISINOPRIL 398 365 2 1
LEVOTHYROXINE SODIUM 370 337 3 3
AMLODIPINE BESYLATE 311 307 4 6
OMEPRAZOLE 253 234 5 4
LOVASTATIN 241 218 6 17
POTASSIUM CHLORIDE 229 208 7 18
METFORMIN HCL 218 179 8 10
FUROSEMIDE 205 185 9 7
ZOLPIDEM TARTRATE 186 175 10 22
ATORVASTATIN CALCIUM 171 156 11 12
ATENOLOL 169 155 12 8
HYDROCHLOROTHIAZIDE 168 149 13 11
TRAMADOL HCL 150 125 14 34
HYDROCODONE-ACETAMINOPHEN 145 119 S3 15 5
DICLOFENAC SODIUM 135 123 16 142
METOPROLOL TARTRATE 134 119 17 14
ALENDRONATE SODIUM 131 130 18 21
FOSINOPRIL SODIUM 104 84 19 226
METOPROLOL SUCCINATE 102 98 20 16
TRAZODONE HCL 99 68 21 23
LOSARTAN POTASSIUM 96 87 22 13
PANTOPRAZOLE SODIUM 95 89 23 40
CARVEDILOL 92 85 24 26
GABAPENTIN 90 65 25 15
PRAVASTATIN SODIUM 87 87 26 20
DIOVAN 86 85 27 58
ALLOPURINOL 83 71 28 28
SERTRALINE HCL 80 63 29 25
GLIMEPIRIDE 79 66 30 48
GEMFIBROZIL 72 56 31 116
JANUVIA 68 62 32 113
CRESTOR 65 48 33 36
CITALOPRAM HBR 65 63 33 19
DIGOXIN 65 55 33 43
ADVAIR DISKUS 62 62 36 37
COMBIVENT 62 62 36 110
IPRATROPIUM BROMIDE 53 53 38 195
FLUOXETINE HCL 50 41 39 31
TRIAMTERENE-HCTZ 50 50 39 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.